top of page
Dr Michael Magee
MBBS, FRACP
Nuclear Medicine Physician
Dr Michael Magee completed his undergraduate medical degree from the University of Sydney in 1980.

Positions held during Training:

  • 1980 – Intern – RNSH, Sydney

  • 1981 – Resident – RNSH

  • 1982 – S.R.M.O (FRACP training) – RNSH

  • 1983 – Medical Registrar (FRACP training) – RNSH

  • 1984 – Nuclear Medicine/Endocrine Registrar – RNSH

  • 1985 – Neurology Registrar – Westmead Hospital, Sydney

  • 1987 – 1988 – Nuclear Medicine Registrar – RNSH, ANSTO Physics Course 1988, Co-author “Clinical Quiz”, Modem Medicine Australia.

  • 1989 – Nuclear Medicine Registrar – RPAH, Sydney, Temporary Visiting Officer in Nuclear Medicine, Repatriation General Hospital, Concord (Dec 1989)

 

Hospital Appointments:

  • 1991 -1992 – Staff Specialist Nuclear Medicine Physician RPAH

  • 1992 – 1994 – Visiting Medical Officer, NM Dept, Concord Hospital

  • 1995 - Present – Staff Specialist NM Physician (P/T), Concord Hospital

  • 1995 – 1998 - Staff Specialist NM Physician (P/T), RNSH

  • 1995 – Locum Staff Specialist NM Physician, St Vincent’s Hospital

  • 1992 – 1994 - Visiting Medical Officer, Sydney Adventist Hospital

  • 1992 – 1996 – Visiting Medical Officer, Strathfield Private Hospital

  • 2010 – Honorary Clinical Lecturer, Macquarie University / ASAM

 

Private Practice Appointments:

  • 1990 – Physician in NM and Thyroid Endocrinology, St George Nuclear Imaging, Illawarra Nuclear Imaging, Shoalhaven Nuclear Imaging.

  • 1991 – 2008 – NM Physician, RPAH Medical Centre, NM (including DEXA Service on Campus from 1991)

  • 2008 – 2011 – NM Physician, Alfred Nuclear and Molecular Imaging.

  • 2008 – Present - Staff Specialist NM Physician, Concord Hospital.

  • 2012 – Present – NM Physician Alfred Nuclear Medicine and Ultrasound Pty Ltd.

 

Memberships:

  • Member of the Australian and New Zealand Society of Nuclear Medicine.

  • Member of the Australian and New Zealand Association for Physicians in Nuclear Medicine.

  • American Society of Nuclear Cardiology

  • ANZAPNM Council Member 1992 – 1994

    • Member of Code of Conduct Subcommittee

    • Author of Code of Conduct for ANZAPNM

 

Textbook Chapters:

  1. Evaluation of Bone SPECT: Vander Wall H, Storey G, Emmett L, Mackey D, Frater C, Magee M.Nuclear Medicine Annual – 2002. Edited by Freeman L, Lippincott Williams and Wilkins, Philadelphia, pgs 215-252.

  2. Bone Scintigraphy in Sports Medicine: Van der Wall H, Kannangara S, Magee M. Nuclear Medicine in Clinical Diagnosis and Treatment, 3rd Edition – 2004. Edited by PJ Ell and SS Gambhir, Churchill Livingston, Edinburgh, Chapter 50, pgs 721-738.

  3. Growth and Metabolic Disorders: Magee M, White CP, Murray IPC. Nuclear Medicine in Clinical Diagnosis and Treatment, 3rd Edition – 2004. Edited by PJ Ell and SS Gambhir, Churchill Livingston, Edinburgh, Chapter 51, pgs 739-757.

  4. Bone Scintigraphy in Arthritis: Van der Wall H, Cusi M, Elison B, Frater C, Bruce W. Radionuclide and Hybrid Bone Imaging (2012). Edited by Fogelman I, Gnanasegaran G and Van der Wall H.Spinger – Verlag Berlin – Heidelberg, Chapter 18, pgs 445-480.

 

Publications:

  1. Haemobilia-Diagnosis by 99mTc-labelled RBC Scintigraphy: ANZJNM. 1990 Oct; 20(5):747-748. Magee M, Hoschl R, Cooper R, Smith R.

  2. Late (one month) reversible ischaemia after primary coronary occlusion treated with recombinant tissue plasminogen activator (rTPA): ANZJNM. 1990 Apr; 20(2):149-153. Wilkes NP, Magee M, Hoschl R, Melson GI.

  3. Current Role pf Gallium Scanning in the Management of Lymphoma: EJNM. 16: 755-771, 1990. McLaughlin AF, Magee M, Greenough R, Allman KC, Southee AE, Meikle SR, Hutton BF, Joshua DE, Boutovich GJ, Morris GJ.

  4. Asystole and Bradycardia during Dipyridamole Stress Testing in Patients receiving Beta Blockers: Int. JCardiology. 1993 Nov;42(1):92-94. Roach PJ, Magee M, Freedman SB.

  5. Tc-99m stannous colloid labeled leukocyte scintigraphy in the evaluation of the painful arthroplasty: Clin. Nucl. Med. 1996 Nov;21(11):838-843. Chik K, Magee M, Bruce W, et al.

  6. Physical properties and use of pertechnegas as a ventilation agent: J Nucl. Med. 1997 Jan;38(1):163-167. Mackey DW, Jackson P, Baker RJ, Dasaklis C, Fisher KJ, Magee M, Bush V, Burch WM, Van der Wall H, Willett GD.

  7. Optimization of the scintigraphic segmental anatomy of the lungs: J Nucl. Med. 1997 Dec;38(12):1987-1991. Magnussen JS, Chicco P, Palmer AW, Mackey DW, Magee M, Murray IP, Bautovich G, Allman K, Storey G, Van der Wall H.

  8. Variability of perceived defect size in virtual lung scintigraphy: J Nucl. Med. 1998 Feb;39(2):361-365. Magnussen JS, Chicco P, Palmer AW, Mackey DW, Magee M, Murray IP, Bautovich G, Allman K, Storey G, Van der Wall H.

  9. Enhanced accuracy and reproducibility in reporting of lung scintigrams by a segmental reference chart: J Nucl. Med. 1998 Jun;39(6):1095-1099. Magnussen JS, Chicco P, Palmer AW, Mackey DW, Magee M, Murray IP, Bautovich G, Allman K, Storey G, Van der Wall H.

  10. Tc-99m stannous colloid-labelled leukocyte scintigraphic localization of an ileoperineal fistula complicating Crohn’s disease: Clin. Nucl. Med. 1998 Aug;23(8):537-538. Storey GR, Allman KC, Magee M, Van der Wall H.

  11. Pain in the Anterior pelvis and postoperative prostatectomy findings: Clin. Nucl. Med. 1999 Jul;24(7):523-524. Van der Wall H, Storey GR, Emmett L, Magee M.

  12. Scintigraphy in severe tenosynovitis of the tibialis posterior tendon: Clin. Nucl. Med. 1999 Sept;24(9):694-695. Kannangara S, Bruce W, Hutabarat SR, Magee M, Van der Wall H.

  13. Single-photon Emission tomography of a computerized model of pulmonary embolism: EJNM. 1999 Nov;26(11):1430-1438. Magnussen JS, Chicco P, Palmer AW, Bush V, Mackey DW, Storey G , Magee M, Bautovich G, Van der Wall H.

  14. A novel view for the scintigraphic assessment of the elbow: Nucl Med Communications 1999 Nov;20(11):1059-1065. Van der Wall H., Frater CJ, Magee M, Kannangara S, Bruce W, Murray IP.

  15. Extensive rhabdomyolysis after streptokinase therapy for acute myocardial infarction demonstrated by Tc-99m PYP scintigraphy: Clin. Nucl. Med. 1999 Dec;24(12):991-992. Emmett L, Patel NC, Thanakrishnan K, Van der Wall H, Magee M, Allman KC.

  16. Paraspinal abscess complicating facet joint injection: Clin. Nucl. Med. 2000 Jan;25(1):71-73. Magee M, Kannangara S, Dennien B, Lonergan R, Emmett L, Van der Wall H.

  17. The role of left ventricular hypertrophy and diabetes in the presence of transient ischaemic dilation of the left ventricle on myocardial perfusion SPECT images: J Nucl. Med. 2005 Oct;46(10):1596-1601. Emmett L, Magee M, Freedman SB, Van der Wall H, Bush V, Trieu J, Val Gaal W, Allman KC, Kritharides L.

  18. Degenerative spondylolysis: a concise report of scintigraphic observations: Rheumatology (Oxford). 2006 Feb;45(2):209-211. Epub 2005 Oct 18. Van der Wall H, Magee M, Reiter L, Frater CJ, Qurashi S, Loneragan R.

  19. Correlative imaging in a typical case of Mazabraud syndrome: AJR Am J Roentgenol 2007 Dec;189(6):W353-356. McLaughlin A, Stailey P, Magee M, Soper J, Van der Wall H.

  20. Prospective evaluation of the impact of diabetes and left ventricular hypertrophy on the relationship between ischaemia and transient ischaemic dilation of the left ventricle on single-day adenosine Tc-99m myocardial perfusion imaging: J Nucl Cardiology. 2008 Sep-Oct;15(5):638-643. Emmett L, Van Gaal WJ, Magee M, Bass S, Ali O, Freedman SB, Van der Wall H, Kritharides L.

  21. Radionuclide bone scintigraphy in sports injuries: Semin Nucl Med.2010 Jan;40(1):16-30.PMID: 19958847. Van der Wall H, Lee A, Magee M, Frater C, Wijesinghe H, Kannangara S.

  22. Progressive visual loss due to obstruction of an optic nerve fenestration demonstrated on SPECT/CT radionuclide cisternography. Clin Nucl Med 2010 Mar:3st(3)208-210. Russo RR, Ha L, Emmett L, Magee M, Mansberg R.

 

Abstracts:

  • In excess of 20 abstracts for posters and/or Oral presentations at National/International Scientific meetings.

value. ​quality care. convenience.

bottom of page